The objective of this study was to examine the relationship between Chlamydia pneumoniae seropositivity and aortic atherosclerotic plaques in the general population. BACKGROUND Seroepidemiologic studies suggest that C pneumoniae infection plays a role in the pathogenesis of atherosclerosis.
Inflammation plays a central role in the pathogenesis of atherosclerotic vascular disease and its atherothrombotic complications (1) . It has been postulated that chronic infection with various pathogens may promote arterial inflammation, thereby contributing to the initiation and/or progression of atherosclerosis (2) . Several large seroepidemiologic studies have observed an association between Chlamydia pneumoniae seropositivity and clinical coronary artery disease (3) (4) (5) and cerebrovascular disease (6) , suggesting that chronic C pneumoniae may play a causal role in the atherosclerotic process. However, these observations are inconsistent with those of other studies (7) (8) (9) (10) . Thus, the importance of C pneumoniae infection in the pathogenesis of atherosclerotic vascular disease remains to be determined (11) .
The Stroke Prevention: Assessment of Risk in a Community (SPARC) study is a National Institutes of Healthfunded, population-based study designed to evaluate the prevalence of risk factors for stroke in the general population (12) (13) (14) . Subjects were evaluated by transesophageal echocardiography (TEE), thereby allowing determination of the frequency and severity of aortic atherosclerosis in the population. The objective of the current study was to examine the relationship between seropositivity for C pneumoniae and anatomically defined atherosclerosis (aortic atherosclerotic plaques identified on TEE) in a sample of the general population, in an attempt to clarify the role of C pneumoniae infection in atherogenesis.
METHODS
Study population. The study design and results of phase I of the SPARC study have been published recently in detail (12, 13) . The original study cohort consisted of 581 subjects, a random sample of Olmsted County (Minnesota) residents Ն45 years old, stratified by age and gender. Approximately four to five years (median 4.6 years, range 3.8 to 5.4 years) after their initial evaluation, eligible subjects were enrolled in phase II of the study. Of 504 subjects eligible for phase II (excluding 3 subjects from the original cohort lost to follow-up, 54 deceased, and 20 with severe medical disabil-ities precluding participation), 392 (78%) agreed to participate (14) . Transesophageal echocardiography was repeated successfully in 388 subjects (99% of phase II participants), 385 of whom were included in the current analysis (two subjects were excluded because of incomplete echocardiographic data, and one subject was excluded because of positive immunoglobulin 
TEE.
Transesophageal echocardiography was performed using commercially available ultrasound instruments equipped with multiplane probes (Sequoia Ultrasound System, Acuson, Mountain View, California). The three segments of the thoracic aorta (ascending aorta, aortic arch, and descending thoracic aorta) were imaged in short-and long-axis views using high-frequency (7-MHz) ultrasonographic imaging. Atherosclerotic plaques were defined as irregular intimal thickening (at least 2 mm thick). The presence of plaques in the thoracic aorta (plaques of any degree in any aortic segment) was determined. Among subjects with plaques, the maximal plaque thickness and the presence of mobile aortic debris (in any segment of the aorta) were determined. For this analysis, plaque thickness was dichotomized arbitrarily at 4 mm (15) and 6 mm (detected in approximately 10% of the study population). Statistical analysis. Continuous data are summarized as medians and interquartile ranges (25% to 75%); categorical data are summarized as percentages. For continuous data, groups were analyzed using the Kruskal-Wallis nonparametric test. For categorical data, groups were analyzed using the chi-square statistic or Fisher exact test (when the expected number of subjects in a cell, under the null hypothesis, was Ͻ5). Logistic regression was used to determine the relationship between C pneumoniae antibody titers and the odds of having aortic plaques (proportion of subjects with plaques of any degree divided by proportion without plaques). Among subjects with plaques, the odds of having plaques Ն4 mm thick (proportion with plaques Ն4 mm divided by proportion with plaques Ͻ4 mm), plaques Ն6 mm thick (proportion with plaques Ն6 mm divided by proportion with plaques Ͻ6 mm), and mobile debris (proportion with plaques with mobile debris divided by proportion with plaques without debris) were determined.
Univariate (unadjusted) odds ratios (ORs) and their 95% confidence intervals (CIs) were estimated. Subsequently, ORs were estimated after adjustment for age, gender (for selected plaque variables), and smoking status (7,16) (7.0% of study participants were current smokers, 38.4% were past smokers, and 54.6% never smoked). Odds ratios were adjusted for gender for plaque variables with a large number of subjects (plaques of any degree and plaques Ն4 mm).
Smoking was modeled as current smoker and past smoker (vs. never smoked) for plaque variables with a large number of subjects or as ever smoked (vs. never smoked) for plaque variables with a small number of subjects (plaques Ն6 mm and mobile debris).
RESULTS
Aortic plaques (of any degree) were detected in 266 subjects (69.1% of subjects). Plaques were uncommon in the ascending aorta (23 subjects, 6.0%) but were common in the aortic arch (243 subjects, 63.1%) and descending thoracic aorta (210 subjects, 54.5%). Plaques Ն4 mm, plaques Ն6 mm, and plaques with mobile debris (in any segment of the aorta) were detected in 113, 41, and 20 subjects, respectively.
Two hundred eighty-seven subjects (74.5%) were C pneumoniae seropositive (IgG titers Ն1:16). Low titers were present in 58 subjects (15.1%), intermediate titers in 144 subjects (37.4%), and high titers in 85 subjects (22.1%). Agmon et al. May 7, 2003 May 7, :1482 C pneumoniae and Aortic Atherosclerosis titers in relation to the presence or absence of specific plaque variables. There was no significant difference in the distribution of C pneumoniae titers between subjects with and those without aortic plaques (of any degree). Among subjects with plaques, there were no significant differences in the distribution of C pneumoniae titers according to the presence or absence of severe plaque characteristics (plaques Ն4 mm, plaques Ն6 mm, and mobile debris). The ORs for aortic plaques in relation to C pneumoniae antibody titers are summarized in Table 2 . Chlamydia pneumoniae titers were not associated with the presence of aortic plaques (of any degree), either univariately or after adjustment for age, gender, and smoking status. Among subjects with plaques, high titer was apparently associated with the presence of plaques Ն4 mm by univariate analysis (OR 2.05, compared with titers Ͻ1:16; 95% CI 1.00 to 4.21), but this association was not significant after adjustment for age, gender, and smoking status (adjusted OR 1.11; 95% CI 0.47 to 2.60). Moreover, the joint inclusion of all three levels of C pneumoniae antibody titers was not a significant addition to the unadjusted model (p ϭ 0.20) or to the age-, gender-, and smoking-adjusted model (p ϭ 0.99) of plaques Ն4 mm. Chlamydia pneumoniae titers were not associated with plaques Ն6 mm or with mobile debris, either univariately or after adjustment for age and smoking status.
The associations between C pneumoniae antibody titers and all plaque variables remained nonsignificant after adjustment for additional aortic atherosclerotic risk factors (data not shown). Furthermore, the association between C pneumoniae titers and severe plaque features remained Data presented are numbers of subjects (percentages of subjects with or without the specific plaque variable in parentheses). *Comparison of subjects with and without the specific plaque variable. Groups were compared using the chi-square statistic, unless otherwise indicated. †Analysis confined to subgroup of 266 subjects with aortic plaques (of any degree). ‡Groups were compared using the Fisher exact test. nonsignificant in an additional post hoc analysis, in which subjects with severe plaque characteristics were compared with the rest of the study population (i.e., compared with subjects with plaques of lesser severity or without plaques; data not shown).
The distribution of C pneumoniae antibody titers was not significantly different between subjects with and those without clinical coronary artery disease and cerebrovascular disease (Table 3 ). Blood cell counts (including white blood cell differential counts), fibrinogen levels, and hs-CRP levels were not significantly different among subjects with various C pneumoniae titers (Table 4) . Data presented are numbers of subjects (percentages of subjects with or without the specific clinical variable in parentheses). *Comparison of subjects with and without the specific clinical variable. Groups were compared using the chi-square statistic, unless otherwise indicated. †Coronary artery disease defined as the presence of any of the following: myocardial infarction, angina pectoris, CABG, or PTCA. ‡Groups were compared using the Fisher exact test. §Cerebrovascular disease defined as the presence of any of the following: ischemic stroke, TIA, or carotid endarterectomy. CABG ϭ coronary artery bypass grafting; Ig ϭ immunoglobulin; PTCA ϭ percutaneous transluminal coronary angioplasty; TIA ϭ transient ischemic attack. 
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DISCUSSION
This population-based TEE study shows that C pneumoniae seropositivity is not associated with the presence of aortic atherosclerotic plaques. Among subjects with plaques, C pneumoniae seropositivity is not associated with plaque severity, as defined by maximal plaque thickness or the presence of mobile debris. The lack of association between C pneumoniae seropositivity and clinical coronary artery disease or cerebrovascular disease in our study population supports our echocardiographic-anatomic observations. C pneumoniae and atherosclerotic plaques. Chlamydia pneumoniae, a common respiratory pathogen, is frequently detected in pathologic specimens of atherosclerotic plaques (17) (18) (19) (20) (21) , but its presence in plaques is related inconsistently with plaque extent and severity (19, 20, 22, 23) . Using various imaging techniques, the relationship between C pneumoniae seropositivity and atherosclerosis has been examined in highly selected patients undergoing invasive angiographic studies (24, 25) and in selected (26 -28) and relatively nonselected (29 -31) populations undergoing noninvasive ultrasonographic vascular imaging. Many of these studies have found positive associations (24, 28, 29, 31) , and two prospective studies have also shown an association between C pneumoniae seropositivity and the progression of carotid atherosclerosis (28, 31) . Nevertheless, these associations were not borne out in a large study of healthy individuals (30) or in our current study. Notably, carotid artery intima-medial thickness, the main measurement used in most ultrasonographic studies, is representative of the early stages of atherogenesis. By contrast, high-resolution, real-time TEE imaging allows visualization of the full range of aortic atherosclerotic plaques, from simple plaques to thick ("protruding") plaques (15) and mobile atherosclerotic debris, the echocardiographic hallmark of ruptured aortic plaque with superimposed thrombosis (32) . Using TEE, we were able to examine the association between C pneumoniae seropositivity and both the presence and complexity of aortic plaques in a large sample of the general population and to conclude that previous (presumably chronic) infection with C pneumoniae, assessed serologically, does not appear to be involved in the atherosclerotic process in either its early or its more advanced stages.
An independent association between hs-CRP and aortic plaques has been demonstrated recently in the SPARC study population (33) , an observation further supporting the systemic inflammatory nature of the atherosclerotic process (1). In our current analysis, C pneumoniae seropositivity was not associated with various markers of systemic inflammation. This observation, also made by other investigators (7, 30) , is consistent with the lack of association between C pneumoniae seropositivity and aortic atherosclerosis in our study population. Study strengths and limitations. The SPARC study is the only large-scale, population-based TEE study performed to date. Study participants were sampled from the adult population residing in a well-defined geographic area, are relatively free of selection bias, and are representative of the general population.
The following study limitations should be noted. First, this was a cross-sectional study, one lacking prospective follow-up data. However, data relating aortic plaque morphology, C pneumoniae serology, and inflammatory markers to future cardiovascular and cerebrovascular events will be available during long-term follow up of the study cohort.
Second, we examined the association between C pneumoniae IgG antibody titers and aortic atherosclerosis, assuming that the presence of IgG titers beyond a certain threshold (i.e., titers Ն1:16) is indicative of chronic C pneumoniae infection (7). Moreover, we examined the association between various levels of antibody titers and aortic atherosclerosis (4,7) and excluded one subject with positive C pneumoniae IgM antibodies, assuming that higher IgG titers are more likely to represent persistent C pneumoniae infection (in the absence of acute infection). Nevertheless, although widely studied (9) and widely available in clinical practice, C pneumoniae IgG antibody titers may not be the best serologic markers for assessing persistent infection, as suggested by the weak association between seropositivity and direct detection of C pneumoniae in atherosclerotic plaques (18, 20, 23) and by the apparently stronger relationship of C pneumoniae IgA titers (3, 6, 34, 35) , C pneumoniae immune complexes (3, 34) , and circulating C pneumoniae deoxyribonucleic acid (36) to atherosclerotic vascular disease.
Third, although we did not demonstrate any significant association between C pneumoniae seropositivity and aortic plaques, it is possible that the sample size of our study was underpowered for detecting minor associations. However, as shown in Table 2 , the adjusted ORs for aortic plaques were close to 1.0 (many of them were Ͻ1.0), and there was no trend for increasing ORs with increasing titers (some ORs for higher titers were even lower than for lower titers). These findings suggest that a significant association between C pneumoniae seropositivity and aortic plaques is very unlikely and, if an association does exist, it is minor and of questionable clinical significance.
Finally, it has been postulated recently that the overall burden of pathogens (i.e., the effect of the combined presence of several infectious pathogens), not a specific pathogen, is the important factor in the development of atherosclerosis (37) . Chlamydia pneumoniae was the only infectious agent examined in our study; therefore, we cannot reject the possibility that persistent C pneumoniae infection, in conjunction with other infectious pathogens, promotes the development of atherosclerosis. Conclusions. Seropositivity for C pneumoniae is not related to the presence or severity of aortic atherosclerotic plaques in the general population. These echocardiographicanatomical findings do not support the hypothesis that C pneumoniae infection plays a role in the pathogenesis of
